The science behind the original and first Skinboosters™
Restylane® SkinboostersTM is the original stabilized hyaluronic acid-based dermal injectable that focuses on the improvement in skin's elasticity and appearance.
What happens with the skin’s hydrobalance as we age?
Hyaluronic acid is a natural substance in our bodies. It can bind huge amounts of water and keeps our body tissues hydrated, soft and flexible.
From the age of 28, we lose around 1% per year of the hyaluronic acid in our skin. With time, or due to exposure to environmental factors, our skin may become dry, fine lines and wrinkles may start to appear, and the skin can lose its radiance1. It is often difficult to restore the skin’s inner hydrobalance by using creams that are applied on the skin's surface. To hydrate and improve skin texture from within, you need treatments that have a long-lasting effect below the skin's surface.
Restoring skin rejuvenation from within
Natural hyaluronic acid in our bodies forms long molecular chains. This naturally occurring hyaluronic acid forms and degrades quickly, within 24-48 hours. Restylane® Skinboosters™ contains hyaluronic acid that has been stabilized with a cross-linking technology, which doesn't degrade at the same rate2.
By injecting micro droplets just below the skin surface, Restylane® Skinbooster™ helps boost skin and improves elasticity3.
Committed to innovation
Galderma empowers everyone to realize their aesthetic goals by providing a diverse portfolio of injectable treatments. With constant innovation and pioneering new technologies, we push the industry forward in our ambition to develop safe aesthetic treatments that live up to, or exceed, patients’ expectations. Learn more about our solutions and our commitment to innovation here.
6.5
million treatments performed to date4
96%
of patients would like to continue or repeat treatment5
12
months - Results that last up to 12 months6
Skin insights
Are you looking for a clinic?
References
- Koblenzer CS. Clin Dermatol 1996;14(2):171–7.; Matsubara et al. Skin Res Technol 2012;18(1):29–35.; Finn CJ et al. Dermatol Surg 2003;29(5):450–455.
- Williams S et al. J Cosmet Dermatol 2009;8(3):216–25.
- Turlier V et al. J Dermatol Sci 2013;69:187–94.; Wang F et al. Arch Dermatol 2007;143:155–63.; Distante F et al. Dermatol Surg 2009;35(S1):389–93.; Gubanova EI et al. J Drugs Dermatol 2015;14(3):288–98.
- Data on File (MA-39929)
- Gubanova EI et al. Aesthetic Med 2010;1:94-98.
- Gubanova EI et al. J Drugs Dermatol 2015;14(3):288–98.